Search Results 61-70 of 391 for ⚠베스트토토검증【평생베스트.com】베스트토토메이저⚠

  1. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers ... Major surgery within 4 weeks of the first dose of study drug; following major ...

  2. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

    This pilot phase I trial studies the side effects and best way to give sirolimus, gemcitabine hydrochloride, and cisplatin in treating patients at high risk ...

  3. https://www.mayoclinic.org/procedure_concepts.xml

  4. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  5. https://www.mayoclinic.org/organization_concepts.xml

  6. A Study to Analyze Sport Nutrition Knowledge and Its Influence on Energy Availability and Body Composition in Athletes - Mayo Clinic

    ... best. Study IDs. Site IRB. La Crosse, Wisconsin: 19-004747. Sponsor Protocol Number: 19-004747. About this study. The purpose of this study is to assess the ...

  7. PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  8. Risk-Based Therapy in Treating Younger Patients with Newly Diagnosed Liver Cancer - Mayo Clinic

    The stage of the cancer is one factor used to decide the best treatment. Treating patients according to the risk group they are in may help get rid of the ...

  9. https://www.mayoclinic.org/condition_consolidated_concepts.xml

  10. Androgen Deprivation to Enrich PSMA Expression and Improve Sensitivity of Staging PSMA PET/C - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...